Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report) traded down 4% on Monday . The stock traded as low as $1.96 and last traded at $2.16. 694,132 shares were traded during trading, an increase of 122% from the average session volume of 312,566 shares. The stock had previously closed at $2.25.
Wall Street Analyst Weigh In
Several research analysts have commented on TKNO shares. Zacks Research raised Alpha Teknova to a “hold” rating in a research report on Wednesday, December 10th. Weiss Ratings restated a “sell (d-)” rating on shares of Alpha Teknova in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $8.00.
Read Our Latest Stock Report on TKNO
Alpha Teknova Price Performance
Institutional Trading of Alpha Teknova
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Balyasny Asset Management L.P. lifted its stake in Alpha Teknova by 19.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,000,484 shares of the company’s stock worth $4,912,000 after purchasing an additional 163,526 shares during the period. Roubaix Capital LLC raised its holdings in shares of Alpha Teknova by 89.5% in the 3rd quarter. Roubaix Capital LLC now owns 833,819 shares of the company’s stock worth $5,161,000 after buying an additional 393,881 shares in the last quarter. Conestoga Capital Advisors LLC lifted its position in shares of Alpha Teknova by 2.6% during the 4th quarter. Conestoga Capital Advisors LLC now owns 317,084 shares of the company’s stock worth $1,205,000 after buying an additional 8,145 shares during the period. Geode Capital Management LLC lifted its position in shares of Alpha Teknova by 64.4% during the 2nd quarter. Geode Capital Management LLC now owns 298,850 shares of the company’s stock worth $1,468,000 after buying an additional 117,016 shares during the period. Finally, Royce & Associates LP acquired a new stake in Alpha Teknova in the 4th quarter valued at $1,116,000. Institutional investors own 13.81% of the company’s stock.
About Alpha Teknova
Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.
The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.
Further Reading
- Five stocks we like better than Alpha Teknova
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.
